Dallas-Fort Worth Life Sciences – BioTech Guide
  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact
Category:

INVESTMENT

  • INVESTMENT

    Lyda Hill Philanthropies Commits $750K to Cancer Prevention

    by ddankesreiter@dallaschamber.org December 17, 2025
    by ddankesreiter@dallaschamber.org December 17, 2025

    Stopping cancer before it starts is the aim of a new prevention-first approach from the Dallas-based Cancer Prevention Initiative (CPI) and Lyda Hill Philanthropies, which committed a $750,000 matching challenge …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWS

    CPRIT Awards Grants to 15 Dallas-Fort Worth Researchers

    by ddankesreiter@dallaschamber.org December 10, 2025
    by ddankesreiter@dallaschamber.org December 10, 2025

    The Cancer Prevention and Research Institute of Texas approved 15 grants in November totaling nearly $18.4 million for North Texas researchers and institutions in its latest funding round, part of …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWS

    UTA Gets $1.48M NIH Grant to Study Immune System

    by ddankesreiter@dallaschamber.org November 19, 2025
    by ddankesreiter@dallaschamber.org November 19, 2025

    The University of Texas at Arlington has landed a $1.84 million federal grant to study how the body’s immune defenses can sometimes go wrong, and how that knowledge could help …

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    Dallas Biotech Raises $40M for ‘Whole-Body Intelligence’ 

    by ddankesreiter@dallaschamber.org November 12, 2025
    by ddankesreiter@dallaschamber.org November 12, 2025

    Curve Biosciences founder and CEO, Plano-born Ritish Patnaik, says “chronic diseases are on the rise, and healthcare costs are skyrocketing as a result.” From its newly established HQ at Pegasus …

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    Local Consumer Goods Co to Acquire Tylenol Maker

    by ddankesreiter@dallaschamber.org November 3, 2025
    by ddankesreiter@dallaschamber.org November 3, 2025

    Kimberly-Clark plans to acquire Kenvue Inc., a personal care product provider with brands like Tylenol, in a deal that values the target at about $48.7 billion. The cash and stock …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWS

    $50M U.S. HQ and Pharmaceutical Facility Coming to Allen

    by ddankesreiter@dallaschamber.org October 24, 2025
    by ddankesreiter@dallaschamber.org October 24, 2025

    BMK Pharma has announced plans to open its 50,000-square-foot U.S. headquarters in Allen. The facility will serve as both a 503B compounding pharmacy and a sterile Contract Development and Manufacturing …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWS

    Oversubscribed pre-seed Round for Chronic Pain Startup

    by ddankesreiter@dallaschamber.org October 13, 2025
    by ddankesreiter@dallaschamber.org October 13, 2025

    Leon Jacobson started Nerveli, a science-backed, AI-powered platform, after going to nearly two dozen doctors for his chronic pain. Now, backed by 20 investors in a new special purpose vehicle …

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    Spineart Lands Investment for Next Phase Growth

    by ddankesreiter@dallaschamber.org October 2, 2025
    by ddankesreiter@dallaschamber.org October 2, 2025

    Spineart, a global medtech innovator, which opened an innovation center in Dallas in 2024, recently announced a CHF (Swiss franc) 25 million capital increase. This new funding will fuel Spineart’s …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWS

    UTSW Wins $12M NCI ‘SPORE’ for Liver Cancer

    by ddankesreiter@dallaschamber.org September 24, 2025
    by ddankesreiter@dallaschamber.org September 24, 2025

    UT Southwestern in Dallas will lead three liver cancer projects on prevention, recurrence, and immunotherapy. It joins Mayo Clinic and MD Anderson as a national NCI SPORE site, a program …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWS

    Where Computer Science Meets Life Science

    by ddankesreiter@dallaschamber.org September 12, 2025
    by ddankesreiter@dallaschamber.org September 12, 2025

    University of Texas at Arlington computer science professor, Junzhou Huang, has secured $3.1 million in federal funding to tackle one of medicine’s most time-consuming challenges: figuring out which antibodies will …

    0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Opsin Biotherapeutics Awarded $2.35 Million NIH Grant to Advance Optogenetic Neuromodulation for Chronic Pain
  • Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program
  • UTSW receives ARPA-H award to create functioning artificial liver: Newsroom – UT Southwestern, Dallas, Texas
  • MusiQ Bio Lands $2.6M CPRIT Grant for Cancer Immunotherapy
  • MassChallenge Deepens Dallas Commitment with LHP

Recent Comments

No comments to show.

Social Connect

Facebook Twitter Instagram Pinterest Linkedin Youtube

Recent Posts

  • Opsin Biotherapeutics Awarded $2.35 Million NIH Grant to Advance Optogenetic Neuromodulation for Chronic Pain

  • Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program

  • UTSW receives ARPA-H award to create functioning artificial liver: Newsroom – UT Southwestern, Dallas, Texas

  • MusiQ Bio Lands $2.6M CPRIT Grant for Cancer Immunotherapy

  • MassChallenge Deepens Dallas Commitment with LHP

Categories

  • INVESTMENT (91)
  • NEWS (74)
  • RANKING (4)
  • RELOCATION (24)
  • Uncategorized (10)

CONTACT US

The Dallas Regional Chamber's Economic Development team serves as a single point of contact for companies, site selection consultants and corporate real estate executives examining the region for new and expanding companies.

  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact
Dallas-Fort Worth Life Sciences – BioTech Guide
  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact
  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact